Please Wait...

Humaira Qureshi

Translation skills

Main profile

Humaira Qureshi
Humaira Qureshi
President, Drug Safety Solutions

As President, Drug Safety Solutions, and a member of Bioclinica's executive leadership team, Humaira Qureshi leads the strategic planning and execution of our global drug safety and pharmacovigilance (PV) business. In addition to working in close collaboration with our global PV clients, Humaira oversees all program operational, commercial, and global resourcing aspects. She brings to the role over 20 years experience in clinical and post marketing safety; both strategic and operational. Humaira has demonstrated success in delivery and implementation of PV operational solutions for several top ten global pharmaceutical companies. Prior to joining Bioclinica in 2018, Humaira established and led the global pharmacovigilance business for a London-based company. During her nine years there she demonstrated exceptional customer service management and global resource management skills, delivering numerous large-scale PV engagements. Humaira has participated on a number of Global PV forums focusing on technology, sourcing and process enablement. Humaira is frequently invited to lecture and has presented on a range of PV topics before thousands at industry and academic events in the US, EU, and Asia. Humaira has a Bachelor's degree in Medicinal Biochemistry from Royal Holloway, University of London.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Attending #SCOPE2020? Kevin Bishop, Bioclinica's VP of RTSM, will be speaking about novel clinical trial designs an… https://t.co/VB91P98vwK
Bioclinica (3 days ago)
As #clinicaltrial designs evolve, trial supply management becomes increasingly complex. Adaptive protocols, direct-… https://t.co/cQa00yp9hi
Bioclinica (5 days ago)
#Clinicaltrials are not only more expensive and more complex, they also take longer than ever to execute. Since man… https://t.co/ZUEXpxulq6
Bioclinica (2 weeks ago)
#CTMS is integral to #clinicaltrials, but it can be resource-intensive. That's why we created Bioclinica CTMS Direc… https://t.co/pW9ySieiE2
Bioclinica (2 weeks ago)
Going to SCOPE? Visit Bioclinica at booth 404! #SCOPE2020 https://t.co/MuzWXHoC2y https://t.co/mpveryx7Xs
Bioclinica (3 weeks ago)
In case you missed it: Bioclinica announces additions to Software Solutions leadership. We welcome Guy Crossley, Ri… https://t.co/8VWOO3IPFD
Bioclinica (6 weeks ago)